Skip to main content

Published locations for Enasidenib data in IDH2-mutated AML are basis for combination therapy trials

Primary tabs

  • View
  • Get Stamp Tags
  • Published Locations

Breadcrumb

  1. Home
  3. Enasidenib data in IDH2-mutated AML are basis for combination therapy trials

User login

  • Reset your password
  • /content/enasidenib-data-idh2-mutated-aml-are-basis-combination-therapy-trials
  • /hematologynews/article/145547/aml/enasidenib-data-idh2-mutated-aml-are-basis-combination-therapy
  • /oncologypractice/article/145547/aml/enasidenib-data-idh2-mutated-aml-are-basis-combination-therapy
  • /hematology-oncology/article/145547/aml/enasidenib-data-idh2-mutated-aml-are-basis-combination